27794490|t|The effects of captopril on lipopolysaccharide induced learning and memory impairments and the brain cytokine levels and oxidative damage in rats
27794490|a|Renin-angiotensin system has a role in inflammation and also involves in learning and memory. In the present study, the effects of captopril on lipopolysaccharide (LPS) induced learning and memory impairments, hippocampal cytokine levels and brain tissues oxidative damage was investigated. The rats were divided and treated: [1] saline (Control), [2] LPS (1mg/kg), [3-5] 10, 50 or 100mg/kg captopril 30min before LPS. The treatment was started since six days before the behavioral experiments and continued during the behavioral tests (LPS injection two h before each behavioral experiment). Administration of LPS prolonged the escape latency and traveled path to find the platform in Morris water maze (MWM) test (P<0.01-P<0.001) while, shortened the latency to enter the dark compartment in passive avoidance (PA) test (P<0.001). Pretreatment by all doses of captopril improved performances of the rats in MWM (P<0.05-P<0.001) and also prolonged the latency to enter the dark in PA test (P<0.001). LPS also increased IL-6, TNF-α, malondialdehyde (MDA) and nitric oxide (NO) metabolites in the hippocampal tissues (P<0.05-P<0.001) which were prevented by captopril (P<0.05-P<0.001). The thiol, superoxide dismutase (SOD) and catalase (CAT) in the hippocampus of LPS group were lower than the control (P<0.001) while, they were enhanced when the aniamls were pretreated by captopril (P<0.01-P<0.001). The results of present study showed that captopril improved the LPS - induced learning and memory impairments in rats which were accompanied with attenuating hippocampal cytokine levels and improving the brain tissues oxidative damage criteria.
27794490	4	14	effects of	T080	C1704420
27794490	15	24	captopril	T116,T121	C0006938
27794490	28	46	lipopolysaccharide	T109	C0023810
27794490	47	54	induced	T169	C0205263
27794490	55	63	learning	T048	C0023186
27794490	68	86	memory impairments	T048	C0233794
27794490	95	100	brain	T023	C0006104
27794490	101	109	cytokine	T116,T129	C0079189
27794490	110	116	levels	T080	C0441889
27794490	121	130	oxidative	T169	C0311404
27794490	131	137	damage	T037	C0010957
27794490	141	145	rats	T015	C0034721
27794490	146	170	Renin-angiotensin system	T022	C0035096
27794490	185	197	inflammation	T046	C0021368
27794490	219	227	learning	T041	C0023185
27794490	232	238	memory	T041	C0025260
27794490	266	276	effects of	T080	C1704420
27794490	277	286	captopril	T116,T121	C0006938
27794490	290	308	lipopolysaccharide	T109	C0023810
27794490	310	313	LPS	T109	C0023810
27794490	315	322	induced	T169	C0205263
27794490	323	331	learning	T048	C0023186
27794490	336	354	memory impairments	T048	C0233794
27794490	356	367	hippocampal	T023	C0019564
27794490	368	376	cytokine	T116,T129	C0079189
27794490	377	383	levels	T080	C0441889
27794490	388	401	brain tissues	T023	C0459385
27794490	402	411	oxidative	T169	C0311404
27794490	412	418	damage	T037	C0010957
27794490	423	435	investigated	T169	C1292732
27794490	441	445	rats	T015	C0034721
27794490	476	482	saline	T167	C0036082
27794490	484	491	Control	T096	C0009932
27794490	498	501	LPS	T109	C0023810
27794490	537	546	captopril	T116,T121	C0006938
27794490	560	563	LPS	T109	C0023810
27794490	569	578	treatment	T061	C0087111
27794490	601	605	days	T079	C0439228
27794490	617	639	behavioral experiments	T060	C0683444
27794490	665	681	behavioral tests	T060	C0683444
27794490	683	686	LPS	T109	C0023810
27794490	687	696	injection	T061	C1533685
27794490	715	736	behavioral experiment	T060	C0683444
27794490	739	753	Administration	T061	C1533734
27794490	757	760	LPS	T109	C0023810
27794490	761	770	prolonged	T079	C0439590
27794490	782	789	latency	T080	C0205275
27794490	832	860	Morris water maze (MWM) test	T060	C0683444
27794490	899	906	latency	T080	C0205275
27794490	920	936	dark compartment	T058	C3649443
27794490	940	957	passive avoidance	T041	C0871047
27794490	959	961	PA	T041	C0871047
27794490	963	967	test	T060	C0683444
27794490	979	991	Pretreatment	T052	C3539076
27794490	999	1004	doses	T081	C0178602
27794490	1008	1017	captopril	T116,T121	C0006938
27794490	1018	1026	improved	T080	C1272745
27794490	1027	1039	performances	T052	C1882330
27794490	1047	1051	rats	T015	C0034721
27794490	1055	1058	MWM	T060	C0683444
27794490	1085	1094	prolonged	T079	C0439590
27794490	1099	1106	latency	T080	C0205275
27794490	1120	1124	dark	T058	C3649443
27794490	1128	1130	PA	T041	C0871047
27794490	1131	1135	test	T060	C0683444
27794490	1147	1150	LPS	T109	C0023810
27794490	1156	1165	increased	T081	C0205217
27794490	1166	1170	IL-6	T116,T129	C0021760
27794490	1172	1177	TNF-α	T116,T129	C1456820
27794490	1179	1194	malondialdehyde	T109,T123	C0024643
27794490	1196	1199	MDA	T109,T123	C0024643
27794490	1205	1217	nitric oxide	T121,T123,T197	C0028128
27794490	1219	1221	NO	T121,T123,T197	C0028128
27794490	1223	1234	metabolites	T123	C0870883
27794490	1242	1253	hippocampal	T023	C0019564
27794490	1254	1261	tissues	T023	C0459385
27794490	1290	1299	prevented	T061	C0199176
27794490	1303	1312	captopril	T116,T121	C0006938
27794490	1335	1340	thiol	T123	C0574031
27794490	1342	1362	superoxide dismutase	T116,T121,T126	C0038838
27794490	1364	1367	SOD	T116,T121,T126	C0038838
27794490	1373	1381	catalase	T116,T126	C0007367
27794490	1383	1386	CAT	T116,T126	C0007367
27794490	1395	1406	hippocampus	T023	C0019564
27794490	1410	1413	LPS	T109	C0023810
27794490	1414	1419	group	T078	C0441833
27794490	1440	1447	control	T096	C0009932
27794490	1475	1483	enhanced	T052	C2349975
27794490	1493	1500	aniamls	T008	C0003062
27794490	1506	1516	pretreated	T052	C3539076
27794490	1520	1529	captopril	T116,T121	C0006938
27794490	1589	1598	captopril	T116,T121	C0006938
27794490	1599	1607	improved	T080	C1272745
27794490	1612	1615	LPS	T109	C0023810
27794490	1618	1625	induced	T169	C0205263
27794490	1626	1634	learning	T048	C0023186
27794490	1639	1657	memory impairments	T048	C0233794
27794490	1661	1665	rats	T015	C0034721
27794490	1694	1705	attenuating	T052	C0599946
27794490	1706	1717	hippocampal	T023	C0019564
27794490	1718	1726	cytokine	T116,T129	C0079189
27794490	1727	1733	levels	T080	C0441889
27794490	1738	1747	improving	T080	C1272745
27794490	1752	1765	brain tissues	T023	C0459385
27794490	1766	1775	oxidative	T169	C0311404
27794490	1776	1782	damage	T037	C0010957
27794490	1783	1791	criteria	T078	C0243161